Clinical Trial Update: CS DNA MVA Trial in Mampong, Ghana [Phase 1]

View source ↗

Summary

Phase 1 CS DNA MVA malaria vaccine trial in Mampong, Ghana was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• CS DNA MVA

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Malaria | Phase 1 | Status: WITHDRAWN